CASC4-LRRC8D Fusion FISH Probe
The CASC4-LRRC8D Fusion FISH Probe is used to confirm a fusion of the CASC4 and LRRC8D genes. The fusion of the CASC4 and LRRC8D genes has been associated with Sarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
CASC4-LRRC8D-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-RERE | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-REOR | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-REGO | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-REGR | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-REAQ | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-ORRE | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-OROR | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-ORGO | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-ORAQ | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-GORE | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-GOOR | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-GOGO | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-GOGR | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-GOAQ | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-GRRE | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-GROR | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-GRGO | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-GRGR | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-GRAQ | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-AQRE | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-AQOR | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-AQGO | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-AQGR | 20 (40 μL) | 200 μL | ||
CASC4-LRRC8D-20-AQAQ | 20 (40 μL) | 200 μL |
LRRC8D Gene Summary
The Leucine Rich Repeat Containing 8 VRAC Subunit D (LRRC8D) gene is located on chr1 :90286572-90401989 at 1p22.2.
Gene Name: Leucine Rich Repeat Containing 8 VRAC Subunit D
Chromosome: CHR1: 90286572 -90401989
Locus: 1p22.2
CASC4 Gene Summary
The increased expression level of this gene is associated with HER-2/neu proto-oncogene overexpression. Amplification and resulting overexpression of this proto-oncogene are found in approximately 30% of human breast and 20% of human ovarian cancers. Alternatively spliced variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Dec 2010]
Gene Name: Cancer Susceptibility 4
Chromosome: CHR15: 44580908 -44707959
Locus: 15q15.3
Gene Diseases
The CASC4 LRRC8D Fusion has been associated with the following diseases:
Disease Name |
---|
Sarcoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|